Eli Lilly and Co (LLY)
735.70
+10.83
(+1.49%)
USD |
NYSE |
Apr 26, 10:12
Eli Lilly Market Cap: 699.48B for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 689.18B |
| April 24, 2024 | 696.15B |
| April 23, 2024 | 708.98B |
| April 22, 2024 | 695.32B |
| April 19, 2024 | 690.55B |
| April 18, 2024 | 709.22B |
| April 17, 2024 | 713.81B |
| April 16, 2024 | 709.98B |
| April 15, 2024 | 713.81B |
| April 12, 2024 | 714.63B |
| April 11, 2024 | 722.19B |
| April 10, 2024 | 724.46B |
| April 09, 2024 | 719.96B |
| April 08, 2024 | 739.02B |
| April 05, 2024 | 745.60B |
| April 04, 2024 | 730.26B |
| April 03, 2024 | 737.78B |
| April 02, 2024 | 726.35B |
| April 01, 2024 | 723.11B |
| March 28, 2024 | 739.66B |
| March 27, 2024 | 739.87B |
| March 26, 2024 | 736.75B |
| March 25, 2024 | 735.08B |
| March 22, 2024 | 732.67B |
| March 21, 2024 | 732.34B |
| Date | Value |
|---|---|
| March 20, 2024 | 734.81B |
| March 19, 2024 | 734.73B |
| March 18, 2024 | 725.11B |
| March 15, 2024 | 717.04B |
| March 14, 2024 | 723.28B |
| March 13, 2024 | 720.53B |
| March 12, 2024 | 717.78B |
| March 11, 2024 | 698.21B |
| March 08, 2024 | 724.62B |
| March 07, 2024 | 741.75B |
| March 06, 2024 | 741.38B |
| March 05, 2024 | 739.31B |
| March 04, 2024 | 753.27B |
| March 01, 2024 | 743.61B |
| February 29, 2024 | 716.57B |
| February 28, 2024 | 720.34B |
| February 27, 2024 | 726.88B |
| February 26, 2024 | 733.45B |
| February 23, 2024 | 731.19B |
| February 22, 2024 | 731.28B |
| February 21, 2024 | 708.74B |
| February 20, 2024 | 718.00B |
| February 16, 2024 | 743.09B |
| February 15, 2024 | 719.42B |
| February 14, 2024 | 718.97B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
102.65B
Minimum
Oct 10 2019
753.27B
Maximum
Mar 04 2024
276.59B
Average
234.44B
Median
Market Cap Benchmarks
| Amgen Inc | 145.55B |
| Biogen Inc | 29.79B |
| Madrigal Pharmaceuticals Inc | 3.861B |
| Vertex Pharmaceuticals Inc | 102.58B |
| Viking Therapeutics Inc | 7.691B |
Market Cap Related Metrics
| PE Ratio | 129.38 |
| PS Ratio | 19.46 |
| Price to Book Value | 64.94 |
| Price | 735.70 |
| Earnings Yield | 0.77% |
| Operating PE Ratio | 60.25 |
| Normalized PE Ratio | 80.23 |